Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

VBIV

VBI Vaccines, Inc.

VBI Vaccines Inc., a biopharmaceutical company based in Cambridge, Massachusetts, is making strides in the development of vaccines to combat immuno-oncology and infectious diseases. Among its offer...

VBI Vaccines, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

VAL

Valaris

Valaris Limited is a major player in the global offshore contract drilling industry, providing services to oil and gas companies worldwide. With a fleet of state-of-the-art drilling rigs, the compa...

Valaris Annual Report 2023

Healthcare Biotechnology LSE 1-10

CYP

Cynata Therapeutics Limited

Cynata Therapeutics Limited is an Australian company that specializes in developing stem cell technology for human therapeutic use. The company's proprietary Cymerus brand is used in its lead produ...

Cynata Therapeutics Limited Annual Report 2023

Healthcare Biotechnology ASX 1-10

TRIB

Trinity Biotech plc

Irish-based Trinity Biotech plc has announced its latest acquisition in the medical diagnostic products sector. The company develops, manufactures, and markets medical diagnostic products for clini...

Trinity Biotech plc Annual Report 2023

Healthcare Biotechnology NASDAQ 501-1000

ACER

Acer Therapeutics Inc.

Acer Therapeutics Inc., a pharmaceutical firm that specializes in the procurement, development, and marketing of treatments for severe and rare life-threatening illnesses, has a promising pipeline ...

Acer Therapeutics Inc. Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

FICO

Fair Isaac Corporation

Fair Isaac Corporation, a Montana-based company founded in 1956, is making waves with its analytic, software, and data decisioning technologies and services that allow businesses in regions spannin...

Fair Isaac Corporation Annual Report 2023

Technology Biotechnology NYSE 1001-5000

AVRO

AVROBIO, Inc.

Cambridge-based AVROBIO, Inc. is making waves in the biotech industry as a clinical-stage gene therapy company focused on ex vivo lentiviral-based gene therapies to treat rare diseases with only a ...

AVROBIO, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

TBIO

Translate Bio

Telesis Bio, a pioneering synthetic biology company, is making waves in the global marketplace with its wide range of synthetic biology instruments, reagents, and associated products and services p...

Translate Bio Annual Report 2019

Healthcare Biotechnology NASDAQ 51-200

TOCA

Tocagen

Tocagen, a biopharmaceutical company, aims to develop cancer-selective gene therapy products to fight cancer by increasing the lifespan of patients with advanced local and metastatic cancer. Their ...

Tocagen Annual Report 2018

Healthcare Biotechnology NASDAQ 51-200

CTXR

Citius Pharmaceuticals, Inc.

Late-stage pharmaceutical company Citius Pharmaceuticals, Inc. is a major innovator in the development and commercialization of critical care products. Covering a wide array of medical solutions, t...

Citius Pharmaceuticals, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

STIM

Neuronetics

Malvern, Pennsylvania-based Neuronetics, Inc. is a commercial stage medical technology company that caters to patients with neurohealth disorders across the globe. The firm specializes in designing...

Neuronetics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

ATE

Alten

Antibe Therapeutics is a biotechnology company with a focus on developing innovative treatments for inflammation. The company aims to cater to the non-addictive management of chronic and post-surgi...

Alten Annual Report 2023

Healthcare Biotechnology TSX-V 11-50

BNO

Bionomics Limited

Bionomics Limited, an Australian and US-based clinical-stage biopharmaceutical company, focuses on discovering and developing new drug candidates to address central nervous system disorders and cer...

Bionomics Limited Annual Report 2023

Healthcare Biotechnology ASX 11-50

INSM

Insmed

Insmed Incorporated, a prominent biopharmaceutical firm, has been making strides in developing and selling cutting-edge therapies to aid patients struggling with critical and rare illnesses. Their ...

Insmed Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

DYAI

Dyadic International

Dyadic International, Inc. - a leading biotechnology platform company - has been making headlines for its cutting-edge research, development, and commercialization of enzymes and other proteins in ...

Dyadic International Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10